Neuroendocrine Tumors: A Multidisciplinary Approach

Editor(s): Papotti, M. (Turin)
de Herder, W.W. (Rotterdam)
 

Endoscopy and Endoscopic Ultrasound in Assessing and Managing Neuroendocrine Neoplasms

O'Toole D.a-c · Palazzo L.d

Author affiliations

aNational Neuroendocrine Tumour Service, St. Vincent's University Hospital, bDepartment of Gastroenterology, St James's Hospital, and cTrinity College, Dublin, Ireland; dService d'Endoscopie, Clinique du Trocadero, Paris, France

Related Articles for ""
Papotti M, de Herder WW (eds): Neuroendocrine Tumors: A Multidisciplinary Approach. Front Horm Res. Basel, Karger, 2015, vol 44, pp 88-103
https://doi.org/10.1159/000382062

Log in to MyKarger to check if you already have access to this content.




Forgot your password
Sign up to MyKarger

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: August 14, 2015
Cover Date: 2015

Number of Print Pages: 16
Number of Figures: 17
Number of Tables: 2

ISBN: 978-3-318-02772-3 (Print)
eISBN: 978-3-318-02773-0 (Online)

Abstract

Despite advances in radiological and metabolic imaging, standard axial endoscopy and endoscopic ultrasonography (EUS) still play a pivotal role in a number of neuroendocrine neoplasms (NENs) of the gastrointestinal and duodenopancreatic region. Upper gastrointestinal endoscopy is essential for the detection and characterization of NEN up to the angle of Treitz (esophageal, gastric and duodenal). Ileocolonoscopy allows the assessing and diagnosing of rectal, colonic and very occasionally distal ileal lesions. Endoscopic assessment is the mainstay for diagnosing gastric NENs associated with hypergastrinemia, but is also useful in detecting and diagnosing duodenal NENs (both functional and nonfunctional) and ampullary NENs. As rectal NENs are on the increase, standard colonoscopy (often combined with endorectal EUS) is also useful in detecting and treating small rectal NENs. EUS is the modality of choice for diagnosing pancreatic NENs and for locoregional staging of esophageal, gastric, duodenal, pancreatic and rectal NENs. This chapter will expand on the diagnostic and therapeutic role of endoscopy and EUS in the field of gastrointestinal and pancreatic NENs.

© 2015 S. Karger AG, Basel



Related Articles:

References

  1. Delle Fave G, Kwekkeboom DJ, van Cutsem E, Rindi G, Kos-Kudla B, Knigge U, et al: ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012;95:74-87.
  2. Schindl M, Kaserer K, Niederle B: Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg 2001;136:49-54.
  3. Ichikawa J, Tanabe S, Koizumi W, Kida Y, Imaizumi H, Kida M, et al: Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003;35:203-206.
  4. Debelenko LV, Emmert-Buck MR, Zhuang Z, Epshteyn E, Moskaluk CA, Jensen RT, et al: The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997;113:773-781.
  5. Norton JA, Melcher ML, Gibril F, Jensen RT: Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery 2004;136:1267-1274.
  6. Norton JA, Warren RS, Kelly MG, Zuraek MB, Jensen RT: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003;134:1057-1063, discussion 1063-1065.
  7. Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E: Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993;104:994-1006.
  8. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, et al: ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 1999;116:532-542.
  9. Merola E, Sbrozzi-Vanni A, Panzuto F, D'Ambra G, Di Giulio E, Pilozzi E, et al: Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology 2011;95:207-213.
  10. Sato Y, Imamura H, Kaizaki Y, Koizumi W, Ishido K, Kurahara K, et al: Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan. Dig Endosc 2014;26:377-384.
  11. Gladdy RA, Strong VE, Coit D, Allen PJ, Gerdes H, Shia J, et al: Defining surgical indications for type I gastric carcinoid tumor. Ann Surg Oncol 2009;16:3154-3160.
  12. Delle Fave G, Capurso G, Annibale B, Panzuto F: Gastric neuroendocrine tumors. Neuroendocrinology 2004;80(suppl 1):16-19.
  13. O'Toole D, Delle Fave G, Jensen RT: Gastric and duodenal neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2013;26:719-735.
  14. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959.
  15. Dalenback J, Havel G: Local endoscopic removal of duodenal carcinoid tumors. Endoscopy 2004;36:651-655.
  16. Jensen RT, Rindi G, Arnold R, Lopes JM, Brandi ML, Bechstein WO, et al: Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 2006;84:165-172.
  17. Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al: One hundred years after ‘carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-3072.
  18. Shields CJ, Tiret E, Winter DC: Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg 2010;252:750-755.
  19. Keller D, Jaffe J, Philp MM, Haluszka O, Khanna A: Should all endoscopically excised rectal polyps be tattooed? A plea for localization. Surg Endosc 2012;26:3101-3105.
  20. Caplin M, Sundin A, Nillson O, Baum RP, Klose KJ, Kelestimur F, et al: ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 2012;95:88-97.
  21. Abe T, Kakemura T, Fujinuma S, Maetani I: Successful outcomes of EMR-L with 3D-EUS for rectal carcinoids compared with historical controls. World J Gastroenterol 2008;14:4054-4058.
  22. Son HJ, Sohn DK, Hong CW, Han KS, Kim BC, Park JW, et al: Factors associated with complete local excision of small rectal carcinoid tumor. Int J Colorectal Dis 2012;28:57-61.
  23. Kwaan MR, Goldberg JE, Bleday R: Rectal carcinoid tumors: review of results after endoscopic and surgical therapy. Arch Surg 2008;143:471-475.
  24. Park HW, Byeon JS, Park YS, Yang DH, Yoon SM, Kim KJ, et al: Endoscopic submucosal dissection for treatment of rectal carcinoid tumors. Gastrointest Endosc 2010;72:143-149.
  25. Zhou X, Xie H, Xie L, Li J, Fu W: Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis. J Gastrointest Surg 2013;17:1689-1697.
  26. Falconi M, Bartsch DK, Eriksson B, Kloppel G, Lopes JM, O'Connor JM, et al: ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 2012;95:120-134.
  27. Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, et al: Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison. Gastroenterology 1996;111:845-854.
  28. Kann PH, Balakina E, Ivan D, Bartsch DK, Meyer S, Klose KJ, et al: Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study. Endocr Relat Cancer 2006;13:1195-1202.
  29. Triponez F, Dosseh D, Goudet P, Cougard P, Bauters C, Murat A, et al: Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 2006;243:265-272.
  30. Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, et al: Is surgery beneficial for MEN1 patients with small (≤2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg 2006;30:654-662, discussion 663-664.
  31. Jensen RT, Cadiot G, Brandi ML, de Herder WW, Kaltsas G, Komminoth P, et al: ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 2012;95:98-119.
  32. Petrone MC, Poley JW, Bonzini M, Testoni PA, Abdulkader I, Biermann K, et al: Interobserver agreement among pathologists regarding core tissue specimens obtained with a new endoscopic ultrasound histology needle; a prospective multicentre study in 50 cases. Histopathology 2013;62:602-608.
  33. Figueiredo FA, Giovannini M, Monges G, Bories E, Pesenti C, Caillol F, et al: EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc 2009;70:907-914.
  34. Larghi A, Capurso G, Carnuccio A, Ricci R, Alfieri S, Galasso D, et al: Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 2012;76:570-577.
  35. Voss M, Hammel P, Molas G, Palazzo L, Dancour A, O'Toole D, et al: Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut 2000;46:244-249.
  36. Ardengh JC, de Paulo GA, Ferrari AP: EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004;60:378-384.
  37. Figueiredo FA, Giovannini M, Monges G, Charfi S, Bories E, Pesenti C, et al: Pancreatic endocrine tumors: a large single-center experience. Pancreas 2009;38:936-940.
  38. Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, et al: EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci 2012;57:791-800.
  39. Gincul R, Palazzo M, Pujol B, Tubach F, Palazzo L, Lefort C, et al: Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial. Endoscopy 2014;46:373-379.
  40. Ishikawa T, Itoh A, Kawashima H, Ohno E, Matsubara H, Itoh Y, et al: Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010;71:951-959.

Article / Publication Details

First-Page Preview
Abstract of  

Published online: August 14, 2015
Cover Date: 2015

Number of Print Pages: 16
Number of Figures: 17
Number of Tables: 2

ISBN: 978-3-318-02772-3 (Print)
eISBN: 978-3-318-02773-0 (Online)

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Article Tools
Article Details

Table of Contents

Article

Recommend This
TOP